CART-ddBCMA for multiple myeloma: Interim results from phase I study

被引：1

作者：

Frigault, M. ^{[1
]}

Rosenblatt, J. ^{[2
]}

Raje, N. ^{[1
]}

Cook, D. ^{[1
]}

Gaballa, M. ^{[3
]}

Emmanuel-Alejandro, E. ^{[1
]}

Cornwell, C. ^{[4
]}

Banerjee, K. ^{[4
]}

Rotte, A. ^{[4
]}

Heery, C. ^{[5
]}

Avigan, D. ^{[2
]}

Jakubowiak, A. ^{[6
]}

Bishop, M. ^{[6
]}

机构：

[1] MGH Massachusetts Gen Hosp, Canc Ctr, Boston, MA USA

[2] Beth Israel Deaconess Med Ctr, Canc Ctr, Boston, MA USA

[3] Massachusetts Gen Hosp, Canc Ctr, Surg Oncol Div, Boston, MA USA

[4] Arcellx, Clin & Regulatory Affairs, Gaithersburg, MD USA

[5] Arcellx, Clin Dev Dept, Gaithersburg, MD USA

[6] Univ Chicago Med, Canc Ctr, Chicago, IL USA

来源：

ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期

关键词：

D O I：

10.1016/j.annonc.2022.07.746

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

620O

引用

页码：S828 / S828

页数：1

共 50 条

[21] Final results of a phase I study of carfilzomib, lenalidomide, and dexamethasone for heavily pretreated multiple myeloma [J].

Sugiura, Isamu ;

Suzuki, Kenshi ;

Ri, Masaki ;

Chou, Takaaki ;

Takezako, Naoki ;

Sunami, Kazutaka ;

Ishida, Tadao ;

Izumi, Tohru ;

Ozaki, Shuji ;

Shumiya, Yoshihisa ;

Iida, Shinsuke .

INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 111 (01) :57-64

[22] Pomalidomide in Hereditary Hemorrhagic Telangiectasia: Interim Results of a Phase I Study [J].

Samour, Mohamed ;

Saygin, Caner ;

Abdallah, Rashid ;

Kundu, Suman ;

McCrae, Keith R. .

BLOOD, 2016, 128 (22)

[23] Phase 1/2 Study of Elotuzumab in Combination with Bortezomib in Patients with Multiple Myeloma with One to Three Prior Therapies: Interim Results [J].

Jakubowiak, Andrzej J. ;

Bensinger, William ;

Siegel, David ;

Zimmerman, Todd M. ;

Van Tornout, Jan M. ;

Zhao, Carol ;

Singhal, Anil ;

Anderson, Kenneth .

BLOOD, 2009, 114 (22) :1491-1492

[24] Phase 1/2 Study of Elotuzumab in Combination with Lenalidomide and Low Dose Dexamethasone in Relapsed or Refractory Multiple Myeloma: Interim Results [J].

Lonial, Sagar ;

Vij, Ravi ;

Harousseau, Jean-Luc ;

Facon, Thierry ;

Kaufman, Jonathan ;

Mazumder, Amitabha ;

Moreau, Philippe ;

Leleu, Xavier ;

Fry, John ;

Singhal, Anil ;

Jagannath, Sundar .

BLOOD, 2009, 114 (22) :179-180

[25] A phase I study of thymoglobulin for relapsed or refractory multiple myeloma [J].

Keller, Jesse ;

Fiala, Mark A. ;

Dipersio, John ;

Stockerl-Goldstein, Keith ;

Vij, Ravi ;

Heldermon, Coy D. .

LEUKEMIA & LYMPHOMA, 2016, 57 (02) :453-455

[26] Clinical Activity of a Novel Multiple Tyrosine Kinase and Aurora Kinase Inhibitor, ENMD-2076, Against Multiple Myeloma: Interim Phase I Trial Results [J].

Farag, Sherif ;

Zhang, Shuhong ;

Suvanna-sankha, Attaya ;

Liang, Jing ;

O'Bryant, Robyn ;

Lisa, Wood ;

Gupta, Sushil ;

Bray, Mark ;

Sidor, Carolyn Fowler ;

Abonour, Rafat .

BLOOD, 2010, 116 (21) :816-816

[27] Targeted therapy in Multiple Myeloma: Results of first phase I study with everolimus (RAD001) [J].

Guenther, A. ;

Baumann, P. ;

Burger, R. ;

Klapper, W. ;

Schmidmaier, R. ;

Gramatzki, M. .

ONKOLOGIE, 2010, 33 :94-94

[28] A Phase I/II Study of Twice Weekly Ixazomib Plus Pomalidomide and Dexamethasone in Relapsed and Refractory Multiple Myeloma: Results from Phase I Dose Escalation Cohorts [J].

Nadeem, Omar ;

Mo, Clifton C. ;

Laubach, Jacob P. ;

Bianchi, Giada ;

Redd, Robert ;

Barth, Peter ;

Bayliss, Trevor J. ;

Sanchorawala, Vaishali ;

Shune, Leyla ;

Distaso, Alexandra ;

Dalton, Virginia ;

Sperling, Adam S. ;

Amweg, Laura ;

McKenney, Mary ;

Colson, Kathleen ;

Millard, Ella L. ;

Hou, Isabella ;

Savell, Alexandra ;

Masone, Kelly ;

Munshi, Nikhil C. ;

Ghobrial, Irene M. ;

Anderson, Kenneth ;

Richardson, Paul G. .

BLOOD, 2020, 136

[29] EFFECT OF CARFILZOMIB, LENALIDOMIDE, AND DEXAMETHASONE VS LENALIDOMIDE AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA BY LINE OF THERAPY: INTERIM RESULTS FROM THE PHASE 3 ASPIRE STUDY [J].

Dimopoulos, M. A. ;

Stewart, A. K. ;

Rajkumar, S. V. ;

Masszi, T. ;

Spicka, I. ;

Oriol, A. ;

Hajek, R. ;

Rosinol, L. ;

Siegel, D. ;

Mihaylov, G. G. ;

Goranova-Marinova, V. ;

Rajnics, P. ;

Suvorov, A. ;

Niesvizky, R. ;

Jakubowiak, A. ;

San-Miguel, J. ;

Ludwig, H. ;

Zojwalla, N. ;

Tonda, M. ;

Yang, X. ;

Moreau, P. ;

Palumbo, A. .

HAEMATOLOGICA, 2015, 100 :151-152

[30] INTERIM RESULTS OF A PHASE 1 STUDY OF THE NOVEL ENGINEERED TOXIN BODY TAK-169 IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA [J].

Kumar, Shaji ;

Mamuye, Admasu ;

Dabovic, Kristina ;

Wang, Jingyuan ;

Anand, Banmeet ;

Yuet, Amy ;

Dholaria, Bhagirathbhai ;

Roy, Vivek .

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 :A475-A475

← 1 2 3 4 5 →